Key Highlights

  • 29.75% of the float in Quantum Computing Inc (NASDAQ:QUBT) is sold short, with 8.6 days to cover, per published market data (October 16, 2026 intraday). FINRA data for September 30, 2026 recorded 67,348,440 shares short, 33.97% of float, up 4.09% from September 15.
  • 65.1% is the decline from the 52-week high of USD 19.11 to the USD 6.67 quote on October 16, 2026, own arithmetic. Quantum Computing Inc (NASDAQ:QUBT) has a market capitalisation of USD 1.51 billion and has fallen 35.0% from USD 10.26 on January 1.
  • USD 5.6 million was second quarter 2026 revenue at Quantum Computing Inc (NASDAQ:QUBT), against USD 61,000 a year earlier, per the 8-K dated August 10, 2026. Net loss was USD 11.8 million, and cash and investments were USD 1.3 billion.
  • October 14, 2026 is the date of a partnership with INmune Bio applying quantum optimization and AI to Alzheimer's drug research, which was reported to lift the stock. Quantum Computing Inc (NASDAQ:QUBT) next reports on an estimated November 13, 2026.

Valuation Versus Cash

The tension is simple: USD 1.51 billion of market value rests on USD 22.2 million of annualised revenue, 68 times sales on the second quarter annualised, own arithmetic. Yet cash and investments of USD 1.3 billion equal 86% of market capitalisation, own arithmetic. The company is priced like a funded option on quantum hardware, closer to an exploration miner with a large treasury than an operating business. Shorts target the multiple; they are not targeting solvency.

Short Interest Data and Conflicts

Short interest figures conflict. The table shows 29.75% of float and 8.6 days to cover; FINRA data imply 33.97% on 198 million floating shares, own arithmetic, with a 13.85 million share average volume. Either way, 67.35 million shares sold short at USD 6.67 equals USD 449 million, own arithmetic. The 52-week high conflicts too: an August 10 analysis cited a USD 25.84 peak, while the published market data show USD 19.11, which this article uses. The stock sits in the lower third of a 50-day range of USD 6.31 to USD 9.18.

Dilution, Acquisitions and Catalysts

Cash fell from USD 1.5 billion at year end to USD 1.3 billion at June 30, 2026, largely on acquisitions: NHanced Semiconductors at USD 73.1 million plus up to USD 72.0 million of earn-outs, with Luminar Semiconductor and NuCrypt, USD 180 million in total cash per the company. Shares outstanding are 226.35 million. No company-specific catalyst was identified for October 16 beyond the INmune Bio announcement. Insiders reported no trades in three months, and the published beta is 3.75, so moves are amplified in both directions.

Where Things Stand

A squeeze is possible but not signalled. Quantum Computing Inc (NASDAQ:QUBT) has 29.75% of float short and 8.6 days to cover, yet it has fallen 65.1% from its 52-week high, so shorts hold large profits and the stock lacks a dated catalyst. Cash of USD 1.3 billion removes distress as a trigger and reduces near-term dilution risk; the valuation of 68 times annualised revenue keeps the bear argument alive. Covering would need contract wins that convert the NHanced and Luminar assets into revenue. The next dated event is third quarter earnings, estimated for November 13, 2026.